Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis-Reference-Cited by-同舟云学术

Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis

Published:2017-06-22 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Virgili Gianni¹,Parravano Mariacristina²,Evans Jennifer R³,Gordon Iris³,Lucenteforte Ersilia⁴

Affiliation:

1. University of Florence; Department of Translational Surgery and Medicine, Eye Clinic; Largo Brambilla, 3 Florence Italy 50134

2. Fondazione G.B. Bietti per lo studio e la ricerca in Oftalmolologia-IRCCS; Ophthalmology; Via Livenza n 3 Rome Italy 00198

3. London School of Hygiene & Tropical Medicine; Cochrane Eyes and Vision, ICEH; Keppel Street London UK WC1E 7HT

4. University of Florence; Department of Neurosciences, Psychology, Drug Research and Children’s Health; viale Gaetano Pieraccini, 6 Florence Italy 50139

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007419.pub5/epdf/full

Reference139 articles.

1. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial;Ahmadieh;Graefe's Archive for Clinical and Experimental Ophthalmology,2008

2. Azad R Sain S Sharma YR Mahajan D Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study Oman Journal of Ophthalmology 2012 166 70

3. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2;Michaelides;Ophthalmology,2010

4. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3;Rajendram;Archives of Ophthalmology,2012

5. Structural and functional measures of efficacy in response to bevacizumab monotherapy in diabetic macular oedema: exploratory analyses of the BOLT Study (Report 4);Sivaprasad;PloS ONE,2013

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitrectomy as an Adjunct to Treat-and-Extend Anti-VEGF Injections for Diabetic Macular Edema;JAMA Ophthalmology;2024-08-08

3. Comprehensive insights into a decade-long journey: The evolution, impact, and human factors of an asynchronous telemedicine program for diabetic retinopathy screening in Pennsylvania, United States;PLOS ONE;2024-07-12

4. Real world efficacy and durability of faricimab in patients with neovascular AMD (nAMD) who had sub-optimal response to prior anti-VEGF therapy;Eye;2024-07-04

5. Comparative efficacy of anti-vascular endothelial growth factor on diabetic macular edema diagnosed with different patterns of optical coherence tomography: A network meta-analysis;PLOS ONE;2024-06-07